These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1994530)

  • 1. Alloantibodies against donor epidermis and early kidney transplant rejection.
    Moraes JR; Moraes ME; Luo YM; Stastny P
    Transplantation; 1991 Feb; 51(2):370-3. PubMed ID: 1994530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of early kidney transplant rejection by a crossmatch with donor skin.
    Moraes JR; Pettaway C; Stastny P
    Transplantation; 1989 Dec; 48(6):951-2. PubMed ID: 2688207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
    Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
    Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation.
    Thistlethwaite JR; Heffron TG; Stevens L; Buckingham M; Stuart JK; Stuart FP
    Transplant Proc; 1990 Aug; 22(4):1897-8. PubMed ID: 2389478
    [No Abstract]   [Full Text] [Related]  

  • 11. Crossmatch with donor skin: characterization of alloantibodies and correlation with early kidney rejection.
    Moraes JR; Moraes ME; Luo Y; Peters PC; Sagalowsky A; Dawidson I; Lu C; Stastny P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):471-2. PubMed ID: 1990588
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
    Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
    Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
    Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.
    Ogura K; Terasaki PI; Johnson C; Mendez R; Rosenthal JT; Ettenger R; Martin DC; Dainko E; Cohen L; Mackett T
    Transplantation; 1993 Aug; 56(2):294-8. PubMed ID: 8356583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of donor-specific antibodies on graft outcome in pediatric renal transplantation from deceased donors.
    Piątosa B; Kwiatkowska A; Rubik J; Jarmużek W; Kluge P; Grenda R
    Ann Transplant; 2011; 16(4):32-9. PubMed ID: 22210419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
    Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.
    Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure.
    van Kampen CA; Roelen DL; Versteeg-van der Voort Maarschalk MF; Hoitsma AJ; Allebes WA; Claas FH
    Transplantation; 2002 Oct; 74(8):1114-9. PubMed ID: 12438956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.